FDA Seeks More Data on Lilly’s Alzheimer’s Drug Candidate

[ad_1] Business Health Care Health Setback could delay potential commercial introduction by at least several months [ad_2] Source link

FDA Commissioner Denies Wrongdoing in Approval Process for Biogen Alzheimer’s Drug Aduhelm

[ad_1] Robert Califf acknowledged the agency made mistakes when it failed to properly document interactions with the company. [ad_2] Source link

New Alzheimer’s Drug Approved by FDA, Promises to Slow Disease

[ad_1] Health Eisai and Biogen’s Leqembi is the first drug to show that reducing a protein linked to Alzheimer’s helped patients [ad_2] Source link

Twitter Reintroduces Upgraded Subscription Service

[ad_1] Tech Twitter Blue, the social-media platform’s bid to diversify revenue away from ads, returns [ad_2] Source link